Evidence map›Paper›PMID 41994662›Full record

ArticleCureus2026

Melanoma Incidence, Mortality, and Dermatologist Availability Across Selected Urban and Rural Counties in Southwest Missouri.

George Ladas, Derek S Towery

Abstract read
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

George LadasMedicine, Kansas City University of Medicine and Biosciences, Kansas City, USA.
Derek S ToweryDermatology, U.S. Dermatology Partners, Joplin, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Melanoma is the most lethal of the common skin cancers, and its incidence continues to rise in the United States. Access to dermatologic specialty care remains below recommended benchmarks, particularly in rural and nonmetropolitan regions. This descriptive, population-based analysis examined melanoma incidence and dermatologist availability across five selected counties in southwest Missouri, with limited county-level mortality reporting. Age-adjusted melanoma incidence data were obtained from the State Cancer Profiles database (National Cancer Institute and Centers for Disease Control and Prevention) and standardized to the 2000 U.S. population. Dermatologist availability was calculated using National Provider Identifier data and reported as dermatologists per 100,000 population. Nonmetropolitan counties demonstrated comparable or higher melanoma incidence rates alongside substantially lower dermatologist density; however, findings are descriptive and do not establish causal relationships. Melanoma mortality could not be meaningfully compared across counties, as data were suppressed in multiple counties due to low case counts. Greene County, designated as the urban reference county, had the highest dermatologist density and was the only county with non-suppressed mortality data. These findings highlight geographic variation in melanoma incidence and provider distribution while underscoring the challenges of interpreting melanoma burden in sparsely populated regions.

Indexed as

access to health caredermatologist availabilitymelanomamissourirural health disparitiesskin cancer epidemiology

Identifiers

PMID41994662
PMCPMC13080842

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.